NCT06412848 2026-02-24JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment StudyMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyActive not recruiting360 enrolled